NCT00240552 - Fosamprenavir Expanded Access | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

August 31, 2005

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

fosamprenavir

DRUG

Telzir®

Trial Locations (12)

GSK Investigational Site, Lausanne

GSK Investigational Site, Bern

GSK Investigational Site, Basel

GSK Investigational Site, Bruderholz

GSK Investigational Site, Aarau

GSK Investigational Site, Lucerne

GSK Investigational Site, Lugano

GSK Investigational Site, Zurich

GSK Investigational Site, Zurich

GSK Investigational Site, Zurich

GSK Investigational Site, Sankt Gallen

GSK Investigational Site, La Chaux-de-Fonds